|
Kinetic equations and initial concentrations. See Table 2 for references. |
|||
| Reactant |
Molecular variable |
Initial concentration [nM] |
ODE |
|
|
|||
| X1 |
EGF |
to be varied |
d(X1)/dt = -v1 |
| X2 |
EGFR |
80 |
d(X2)/dt = -v1 |
| X3 |
EGF-EGFR |
0 |
d(X3)/dt = v1 - 2v2 |
| X4 |
(EGF-EGFR)2 |
0 |
d(X4)/dt = v2 + v4 - v3 |
| X5 |
EGF-EGFR-P |
0 |
d(X5)/dt = v3 + v7 - v4 - v5 |
| X6 |
PLCγ |
10 |
d(X6)/dt = v8 - v5 |
| X7 |
EGF-EGFR-PLCγ |
0 |
d(X7)/dt = v5 - v6 |
| X8 |
EGF-EGFR-PLCγ-P |
0 |
d(X8)/dt = v6 - v7 |
| X9 |
PLCγ-P |
0 |
d(X9)/dt = v7 - v8 - v9 - v10 |
| X10 |
PLCγ-P-I |
0 |
d(X10)/dt = v9 |
| X11 |
PKC |
10 |
d(X11)/dt = -v10 |
| X12 |
PKC* |
0 |
d(X12)/dt = v10 - v11 |
| X13 |
Raf |
100 |
d(X13)/dt = -v11 |
| X14 |
Raf* |
0 |
d(X14)/dt = v11 - v12 - v14 |
| X15 |
MEK |
120 |
d(X15)/dt = v13 - v12 |
| X16 |
MEK-P |
0 |
d(X16)/dt = v12 + v15 - v13 - v14 |
| X17 |
MEK-PP |
0 |
d(X17)/dt = v14 - v15 - v16 - v18 |
| X18 |
ERK |
100 |
d(X18)/dt = v17 - v16 |
| X19 |
ERK-P |
0 |
d(X19)/dt = v16 + v19 - v17 - v18 |
| X20 |
ERK-PP |
0 |
d(X20)/dt = v18 - v19 |
|
- PKC* and Raf * indicate the activated form of PKC and Raf, respectively. | |||
Wang et al. Theoretical Biology and Medical Modelling 2007 4:50 doi:10.1186/1742-4682-4-50 |
|||